Laddar...
Phase 2 Clinical Trial of Intrathecal Topotecan in Children with Refractory Leptomeningeal Leukemia: A Children’s Oncology Group Trial (P9962)
PURPOSE: We performed a phase 2 study in children with recurrent or refractory leptomeningeal leukemia to determine the objective response rate after treatment with intrathecal topotecan. PATIENTS AND METHODS: Patients received age-adjusted intrathecal topotecan (0.4 mg/dose for patients > 3 year...
Sparad:
| Huvudupphovsmän: | , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2011
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3242923/ https://ncbi.nlm.nih.gov/pubmed/21910214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.23317 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|